Could a simpler pill combo beat h. pylori with fewer side effects?

NCT ID NCT07179159

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 27 times

Summary

This study compares a new 14-day treatment using just two medications (vonoprazan and an antibiotic) against the standard four-drug therapy for eradicating H. pylori, a bacteria that can cause stomach ulcers and cancer. About 372 adults who have never been treated for H. pylori will take part. The goal is to see if the simpler dual therapy works just as well and causes fewer side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Qilu Hospital of Shandong University

    RECRUITING

    Jinan, Shandong, 250012, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Qilu Hospital of Shandong University

    NOT_YET_RECRUITING

    Jinan, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.